GlassScriptPhysician profile
Shweta Agarwal
NPI 1881026078
$531.47
in general payments reported to CMS, 2019-2025
4 companies · $25.73 in 2025
The $25.73 reported for 2025 was less than what a typical Clinical Pathology/Laboratory Medicine provider received nationally (typical 2025 total: $114).
See the full distribution for Clinical Pathology/Laboratory Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.34 · 2021: $29.72 · 2022: $198 · 2023: $169 · 2024: $96.11 · 2025: $25.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $397.29 | 2021-2023 | Omnipod |
| Merz North America, INC. | $100.14 | 2024-2025 | |
| Revance Therapeutics, INC. | $21.70 | 2024 | Daxxify |
| Merck Sharp & Dohme LLC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shweta Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.